Evidence map›Paper›PMID 39352386›Full record

ArticleThe Journal of clinical investigation2024

IFN-γ and YAP lead epithelial cells astray after severe respiratory infection.

Bradley E Hiller, Joseph P Mizgerd

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bradley E HillerPulmonary Center.
Joseph P MizgerdPulmonary Center.

Funding

BIOLOGY OF THE LUNG--MULTIDISCIPLINARY PROGRAMT32HL007035 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton, JOSEPH P MIZGERD · 1985 to 2026
$24.3M
Lung-resident antibacterial heterotypic immunityR01AI115053 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MIZGERD, JOSEPH P · 2015 to 2023
$4.0M
Pulmonary pathophysiology sub-phenotypes of pneumoniaR01AI162850 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI JOSEPH P MIZGERD · 2022 to 2026
$4.0M
Fibrin in the Infected LungR01HL171499 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI JOSEPH P MIZGERD · 2024 to 2026
$2.3M
NHLBI NIH HHS R01 HL171499NHLBI NIH HHS T32 HL007035NIAID NIH HHS R01 AI115053NIAID NIH HHS R01 AI162850
6 · The paper itself

Abstract

Ineffective recovery from pneumonia can lead to interstitial lung disease characterized by aberrant epithelial cells in fibrotic regions. In this issue of the JCI, Lin et al. define molecular pathways leading to the development and persistence of keratin 5+ (Krt5+) epithelial cells in the alveolar parenchyma when mice struggle to recover from influenza infection. The receptor for IFN-γ on lung epithelium was essential for the formation of aberrant Krt5+ cells and fibrotic lung disease. The transcription factor Yes-associated protein 1 (YAP) was necessary for persistence of these Krt5+ cells, and IFN-γ activated YAP in lung epithelial cells via JAK, focal adhesion kinase (FAK), and Src kinases. These findings establish a targetable pathway underlying some of the pulmonary postacute sequelae of pneumonia.

Indexed as

Interferon-gammaYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingAnimalsEpithelial CellsHumansMiceOrthomyxoviridae InfectionsTranscription FactorsAdaptor Proteins, Signal TransducingIFNG protein, mouseInterferon-gammaTranscription FactorsYap1 protein, mouseYAP-Signaling Proteins

Identifiers

PMID39352386
PMCPMC11444161

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.